---
figid: PMC5930956__12885_2018_4387_Fig11_HTML
figtitle: Proposed model for the role of c-Cbl in tamoxifen resistance of HER2-overexpressing
  breast cancer cells
organisms:
- NA
organisms_ner:
- Escherichia coli str. K-12 substr. MG1655
pmcid: PMC5930956
filename: 12885_2018_4387_Fig11_HTML.jpg
figlink: /pmc/articles/PMC5930956/figure/Fig11/
number: F11
caption: Proposed model for the role of c-Cbl in tamoxifen resistance of HER2-overexpressing
  breast cancer cells. In HER2-overexpressing breast cancer cells, ER-c-Src-HER2 complex
  formation results in HER2 signaling pathway activation and tamoxifen resistance.
  c-Cbl reduces ER-c-Src-HER2 complex formation by inhibiting lipid rafts and restores
  the sensitivity to tamoxifen
papertitle: C-Cbl reverses HER2-mediated tamoxifen resistance in human breast cancer
  cells.
reftext: Wei Li, et al. BMC Cancer. 2018;18:507.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9484734
figid_alias: PMC5930956__F11
figtype: Figure
redirect_from: /figures/PMC5930956__F11
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5930956__12885_2018_4387_Fig11_HTML.html
  '@type': Dataset
  description: Proposed model for the role of c-Cbl in tamoxifen resistance of HER2-overexpressing
    breast cancer cells. In HER2-overexpressing breast cancer cells, ER-c-Src-HER2
    complex formation results in HER2 signaling pathway activation and tamoxifen resistance.
    c-Cbl reduces ER-c-Src-HER2 complex formation by inhibiting lipid rafts and restores
    the sensitivity to tamoxifen
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - tam
  - csrC
  - cbl
  - O TAM
  - TAM
---
